Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brain-tumor therapy. Quantitative analysis using a model system

M K Rosenblum, K D Knebel, D A Vasquez

    Journal of Neurosurgery
    |February 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Immunologic aspects of renal diseases.

    JAMA·1992
    Same author

    Magnetic resonance imaging of tuberculum sellae meningiomas: preventing preoperative misdiagnosis as pituitary macroadenoma.

    Neurosurgery·1992
    Same author

    Ontogeny of T lymphocyte function in the neonate.

    American journal of reproductive immunology (New York, N.Y. : 1989)·1992
    Same author

    Heparin decreases mesangial matrix accumulation after selective antibody-induced mesangial cell injury.

    Journal of the American Society of Nephrology : JASN·1992
    Same author

    Positron emission tomography for tumour assessment.

    NMR in biomedicine·1992
    Same author

    Radiosurgery: a new application?

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1992

    Evaluating 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy in rat brain tumors revealed that drug penetration, not damage repair, limits efficacy. Tumor size measurements are unreliable for assessing brain tumor treatment effectiveness.

    Area of Science:

    • Oncology
    • Pharmacology
    • Cancer Research

    Background:

    • 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) is a chemotherapy agent used for brain tumors.
    • Evaluating treatment efficacy is crucial for improving patient outcomes.

    Purpose of the Study:

    • To assess the in vivo efficacy of BCNU therapy in a transplantable rat brain tumor model.
    • To investigate the mechanisms limiting BCNU's therapeutic effect.
    • To evaluate the reliability of tumor size measurements in assessing treatment response.

    Main Methods:

    • Utilized a colony-formation assay to determine the fraction of surviving clonogenic tumor cells after BCNU treatment.
    • Compared in vitro colony-forming capacity of treated and untreated tumor cells.
    • Monitored tumor weight changes and cell regrowth kinetics post-treatment.

    Related Experiment Videos

    Main Results:

    • The plateau in the BCNU dose-response curve is attributed to limited drug penetration, not repair of lethal or sublethal damage.
    • A high dose of BCNU (killing >99.9% of cells) resulted in only a 60% decrease in tumor weight.
    • Surviving cells showed a regrowth latency of 2-4 days with a doubling time of 40 hours.
    • Significant variability in tumor response and regrowth was observed.

    Conclusions:

    • Limited BCNU penetration into the tumor is a primary factor restricting its efficacy.
    • Tumor size measurements are insufficient for accurately evaluating brain tumor therapy due to factors like delayed cell death removal.
    • Understanding tumor cell kinetics and heterogeneity is vital for optimizing combination chemotherapy and multimodality treatment strategies.